26 November 2014 - Deborah Wilkes
Archived
The US Federal Trade Commission (FTC) has approved the formation of the consumer healthcare joint venture between GlaxoSmithKline and Novartis following a product divestment.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.